Prostate cancer decisions — 2025

The veteran's left inguinal hernia is service-connected as secondary to his prostate cancer. The decision is based on evidence showing the hernia is at least as likely as not due to the prostate cancer.

The veteran's claim for a higher disability rating for tinnitus was denied. Other claims related to prostate cancer residuals, PTSD, TDIU, and DEA benefits were remanded for further review.

The Board denied the appellant's claim for accrued benefits because there was no pending claim at the time of the Veteran's death and no periodic monetary benefits owed.

The Board remanded the claim for service connection for a back disability. All other claims were not warranted for readjudication.

The Board remanded all issues for further development, including obtaining medical opinions and referring the prostate cancer claim for extraschedular consideration.

The Board granted an earlier effective date of August 16, 2019, for compensation for prostate cancer. The Veteran's claim was based on VA's failure to timely diagnose and treat the condition.

The Board granted service connection for bladder cancer and remanded claims for a urinary disorder and erectile dysfunction, while denying prostate cancer.

The veteran's claims for service connection for amyloidosis, diabetes mellitus (DMII), and hypertensive disease were denied. However, the claim for service connection for prostate cancer residuals was granted.

The Board remanded the veteran's claims for service connection of multiple conditions due to herbicide agent exposure. The decision was based on the need for additional development and verification of the veteran's claimed exposure.

The Board remanded the claim for a total disability rating based on individual unemployability due to service-connected disabilities. The Veteran's case was sent back for further development, including VA examinations and opinions on employability.

The appeal for service connection of prostate cancer is remanded. The Board needs to verify the Veteran's service in the Panama Canal zone and obtain complete service records.

The Board denied the veteran's appeals for an increased rating for prostate cancer residuals and a compensable rating for erectile dysfunction.

The veteran's appeal for service connection of prostate cancer was dismissed because the veteran withdrew the appeal.

The appeal for service connection of prostate cancer prior to August 10, 2022 is remanded. The Board needs more evidence to decide if the veteran's prostate cancer is related to his service.

The veteran's claims for service connection for abnormal weight gain or obesity and hypercholesterolemia or high cholesterol were denied. The claims for diabetes mellitus type II, hypertension, and prostate cancer were remanded for further evaluation.

The Board remanded the veteran's claims for service connection for diabetes mellitus type II, prostate cancer, and ischemic heart disease due to inadequate medical opinions.

The Board remanded the claims for service connection for prostate cancer and bladder cancer. The Veteran's exposure to herbicides at Fort Knox during his service will be investigated.

The appeal for prostate cancer was dismissed because it was already granted. The veteran's rating for a left foot disorder was restored to 20%. The appeals for higher ratings for the left foot and knee disorders were remanded.

The Veteran's claim for a higher rating for prostate cancer residuals was denied, and the reduction from 100% to 40% effective October 1, 2018 is upheld.

The Veteran's claim for service connection for prostate cancer due to exposure to herbicide agents has been granted.,The Veteran's claim for service connection for squamous cell carcinoma (SCC) due to participation in a toxic-related exposure activity (TERA) is remanded.